RNAi-Mediated inhibition of tumor necrosis factor alpha-related conditions

Details for Australian Patent Application No. 2012201409 (hide)

Owner Alcon Research, Ltd.

Inventors Gamache, Daniel A.; Senchyna, Diane Michelle; Miller, Steven T.; Chatterton, Jon E.; Yanni, John M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012201409

Parent 2007253776

Filing date 8 March 2012

Wipo publication date 29 March 2012

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

29 March 2012 Application Open to Public Inspection

  Published as AU-A-2012201409

29 March 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201410-Liquid extraction filter and method for cleaning it

2012201408-Overhead boat storage system